Ticker: IOBT

IO Biotech, Inc. (NASDAQ: IOBT) - quick internal readout Snapshot (as of June 30, 2025) * Cash and cash equivalents: $28,131 (in thousands) - down from $60,031 at 12/31/2024. * Total assets: $42,326; Total liabilities: $40,734; Stockholders' equity: $1,592. * Accumulated deficit: $(407,951) (in t...

Company Overview: IO Biotech, Inc. (NASDAQ: IOBT) is a clinical-stage biopharmaceutical company focused on developing novel immune-modulatory therapeutic cancer vaccines utilizing its T-win® platform. Recent Income Statement Highlights for Q1 2025: Net Loss: $22.4 million, compared to $19.5 mill...